Efficacy of CMV antigeemia directed preemptive therapy with ganciclovir at one year in liver transplant recipients pretreated with thymoglobulin or alemtuzumab

Kwak, E. J., Husain, S., Paterson, D. L., Fontes, P., Cacciarelli, T., Marcos, A., Fung, J. and Eghtesad, B. (2004). Efficacy of CMV antigeemia directed preemptive therapy with ganciclovir at one year in liver transplant recipients pretreated with thymoglobulin or alemtuzumab. In: American Transplant Congress, Boston MA, (502-502). 14-19 May 2004.

Author Kwak, E. J.
Husain, S.
Paterson, D. L.
Fontes, P.
Cacciarelli, T.
Marcos, A.
Fung, J.
Eghtesad, B.
Title of paper Efficacy of CMV antigeemia directed preemptive therapy with ganciclovir at one year in liver transplant recipients pretreated with thymoglobulin or alemtuzumab
Conference name American Transplant Congress
Conference location Boston MA
Conference dates 14-19 May 2004
Journal name American Journal of Transplantation   Check publisher's open access policy
Place of Publication Malden, MA, United States
Publisher Wiley-Blackwell
Publication Year 2004
Sub-type Published abstract
ISSN 1600-6135
1600-6143
Volume 4
Start page 502
End page 502
Total pages 1
Language eng
Q-Index Code EX
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Conference Paper
Collection: UQ Centre for Clinical Research Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Google Scholar Search Google Scholar
Created: Tue, 07 Sep 2010, 17:04:38 EST